Does CAMRELIZUMAB Cause Hepatic function abnormal? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Hepatic function abnormal have been filed in association with CAMRELIZUMAB. This represents 4.2% of all adverse event reports for CAMRELIZUMAB.
18
Reports of Hepatic function abnormal with CAMRELIZUMAB
4.2%
of all CAMRELIZUMAB reports
2
Deaths
3
Hospitalizations
How Dangerous Is Hepatic function abnormal From CAMRELIZUMAB?
Of the 18 reports, 2 (11.1%) resulted in death, 3 (16.7%) required hospitalization.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAMRELIZUMAB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does CAMRELIZUMAB Cause?
Myelosuppression (70)
Fatigue (60)
Nausea (60)
Vomiting (59)
Diarrhoea (54)
Anaemia (53)
Hypothyroidism (53)
Off label use (52)
Rash (50)
Thrombocytopenia (46)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which CAMRELIZUMAB Alternatives Have Lower Hepatic function abnormal Risk?
CAMRELIZUMAB vs CANAGLIFLOZIN
CAMRELIZUMAB vs CANAGLIFLOZIN\METFORMIN
CAMRELIZUMAB vs CANAKINUMAB
CAMRELIZUMAB vs CANDESARTAN
CAMRELIZUMAB vs CANDESARTAN CILEXETIL